ArticleJournal of clinical medicine2022

Tocilizumab for the Treatment of Familial Mediterranean Fever-A Randomized, Double-Blind, Placebo-Controlled Phase II Study.

Joerg C Henes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.